Eric B. Springman,Margaret McCrann Pugh,Lopa Bhatt,Ralph Grosswald
申请号：
US16443338
公开号：
US20200138791A1
申请日:
2019.06.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention is directed to methods of inhibiting LTA4-h in a human patient and method of treating a condition ameliorated by the inhibition of leukotriene A4 hydrolase activity in a human patient comprising administering to said human patient the compound, 4-{5-[4-(4-Oxazol-2-yl-phenoxy)-benzyl]-2,5-diaza-bicyclo[2.2.1]hept-2-ylmethyl}-benzoic acid.
